Antiandrogen-Estrogen Therapy for Signs of Androgenization / / ed. by Adolf E. Schindler.

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990
MitwirkendeR:
HerausgeberIn:
Place / Publishing House:Berlin ;, Boston : : De Gruyter, , [2019]
©1987
Year of Publication:2019
Edition:Reprint 2019
Language:English
Series:New Developments in Biosciences ; 3
Online Access:
Physical Description:1 online resource (244 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Welcome address
  • Contents
  • Introduction
  • Antiandrogen therapy for signs of androgenization: an overview
  • I. Pharmacology and physiology
  • Pharmacological aspects of cyproterone acetate
  • Pharmacokinetics of cyproterone acetate and ethinyl estradiol in smoking and non-smoking women during treatment with Diane-35
  • Ovulation inhibitory effect of SH B 209 AE (Diane-35)—a new antiandrogen-estrogen combination
  • A study to investigate the maintenance of ovulation inhibition when patients switch over from Diane to Diane-35
  • Effect of a new antiandrogen-estrogen sub-fifty combination on the endometrium
  • II. Polycystic ovary syndrome
  • Endocrinological and clinical findings on the therapy with Diane-35 in polycystic ovary syndrome
  • Discussion
  • III. Effects on the haemostatic system
  • Longitudinal study on the effects of a cyproterone acetate and ethinyl estradiol combination on haemostasis
  • Haemorheological effects of Diane-35 and Microgynon®—Preliminary results of a double blind study
  • Antiandrogen treatment in women with acne: a controlled trial
  • IV Special aspects
  • Clinical assessment of two antiandrogen treatments, cyproterone acetate combined with ethinyl estradiol and spironolactone in hirsutism
  • Treatment of severe androgenization symptoms with Diane and intramuscularly applied cyproterone acetate (Androcur Depot)
  • One-year experience with a new oral contraceptive using natural estradiol and cyproterone acetate
  • Discussion
  • V. Metabolic and clinical aspects
  • Clinical and metabolic effects of a new estrogenantiandrogen low dose combination
  • Effects of cyproterone acetate on serum lipoproteins when administered alone and in combination with ethinyl estradiol
  • Clinical, metabolic and endocrine effects of long term use of a cyproterone acetate and ethinyl estradiol combination in hyperandrogenized women
  • Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne : results of a multi-center study
  • Comparison of Diane-35 with Neo-Eunomin from the dermatological viewpoint
  • A double blind comparative study of tetracycline and Diane, alone and in combination in the treatment of acne
  • The comparative efficacy and safety of Diane- 35 versus Diane-50 in the treatment of moderate to severe acne and seborrhea: preliminary results
  • Results of an extended open phase m study with Diane-35
  • Discussion
  • Closing remarks
  • List of first-mentioned contributors